CRF2 Human Corticotropin-Releasing Factor GPCR Cell Based Agonist & Antagonist cAMP LeadHunter Assay - FR
OVERVIEW
DOCUMENTS/REFERENCES
Biological Information
No. of Assays on Panel:
2
Assays on Panel:
Family
GPCR
Name
CRF2 Human Corticotropin-Releasing Factor GPCR Cell Based Agonist cAMP LeadHunter Assay - FR
Item
2085
Protein
CRF2
Organism
Human
Assay Sub Type
Cell Based
Family
GPCR
Name
CRF2 Human Corticotropin-Releasing Factor GPCR Cell Based Antagonist cAMP LeadHunter Assay - FR
Item
2086
Protein
CRF2
Organism
Human
Assay Sub Type
Cell Based
Family:
GPCR
Sub Family:
Corticotropin-Releasing Factor
Class:
Class B
Protein Name:
CRF2
Uniprot Number:
Q13324
Protein Aliases:
CRF-R2|CRFR-2|Corticotropin-releasing hormone receptor 2|CRH-R-2|CRH-R2
Gene Name:
CRHR2
Gene ID:
1395
Gene Aliases:
CRF2|CRF-RB|HM-CRF|CRF2R|CRH2R
Organism:
Human
Cell Type:
HEK293
Assay Information
Assay Type:
Functional
Assay Sub Type:
Cell Based
Functional Mode:
Agonist & Antagonist
Detection Method:
HTRF
Testing Information
Incubation:
30 min at RT
Control Activator:
human CRF (100 nM)
Test Concentration / Dose:
Eurofins will provide IC/EC50 calculation if 5 or more concentrations are selected.
Test Sample Requirements:
Minimum for 1) Screen: 60 µL of 10 mM stock -OR- 1 mg (pre-weighed) for 10µM finµL testing. 2) Dose Response: 90 µL of 10 mM stock -OR- 1 mg (pre-weighed) for a top concentration at 10 µM.
Minimum Order Quantity:
16
Turnaround Time
Standard:
15 Business Days
Clinical Relevance
Therapeutic Area:
Inflammation/Allergy
Additional Information
Brand:
LeadHunter
Testing Location:
France - Celle L'Evescault
RELATED SOLUTIONS
CRF2 Human Corticotropin-Releasing Factor GPCR Cell Based Agonist cAMP LeadHunter Assay - FR
Item: 2085
CRF2 Human Corticotropin-Releasing Factor GPCR Cell Based Antagonist cAMP LeadHunter Assay - FR
Item: 2086
Questions? Contact Us
You can easily get in touch with a Eurofins Discovery Expert or get help from our Customer Service team. Reach out with questions, or to discuss your specific discovery challenges.
